Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 2092

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 9A
Chunk 2092
---
 vest annually over five years, rather than quarterly, with the
first vesting date being December 31, 2024. The initial grant and subsequent amendment of Mr. Miller’s options was contingent
upon the stockholders of the Company approving the amendment to the exercise price of the options and approving the amendment to the
2022 Plan to increase the number of shares available under the 2022 Plan in order to comply with Listing Rule 5635(c) of The Nasdaq
Stock Market LLC. On July 16, 2024, the Company’s stockholders approved the proposal to increase the number of shares
available under the 2022 Plan. As of that date, Mr. Miller’s option grant, as subsequently amended, was considered
effective.

We may terminate Mr. Miller’s employment
hereunder for Cause, as defined in the Miller Employment Agreement, at any time upon notice to Mr. Miller setting forth in reasonable
detail the nature of such Cause. We also may terminate Mr. Miller’s employment other than for Cause at any time upon thirty (30)
days’ written notice to him. Mr. Miller may terminate his employment for Good Reason, as defined in the Miller Employment Agreement,
at any time upon thirty (30) days’ written notice to us. In the event that Mr. Miller’s employment is terminated other than
for Cause or for Good Reason, Mr. Miller will be entitled to, among other things, a continuation of his annual salary plus health insurance
benefits for a period not exceeding 18 months. In addition, in the event of a Change in Control, as defined in the Miller Employment
Agreement, on, or at any time during the 24 months following, the Change in Control, (i) we terminate Mr. Miller’s employment for
any reason other than Cause or Disability, as defined in the Miller Employment Agreement, or (ii) Mr. Miller terminates his employment
for Good Reason, Mr. Miller will be entitled to Change in Control severance. 

Mr. Miller is subject to non-competition and
non-solicitation during the term of his employment and for a period of 24 months after termination of his employment.

Landon Employment Agreement.
We entered into an Employment Agreement dated as of February 7, 2024 with Kristen Landon (the “Landon Employment
Agreement”), our Chief Commercial Officer. The term of the Landon Employment Agreement began on February 12, 2024 and will
continue at will, meaning